Article Versions Notes

Guerra MV, Castro J, Moreno A, Balboa E, Marugan JJ, Alvarez AR, Zanlungo S. c-Abl/TFEB Pathway Activation as a Common Pathogenic Mechanism in Lysosomal Storage Diseases: Therapeutic Potential of c-Abl Inhibitors. Antioxidants. 2025; 14(5):611. https://doi.org/10.3390/antiox14050611

Guerra, Miguel V., Juan Castro, Antonio Moreno, Elisa Balboa, Juan J. Marugan, Alejandra R. Alvarez, and Silvana Zanlungo. 2025. "c-Abl/TFEB Pathway Activation as a Common Pathogenic Mechanism in Lysosomal Storage Diseases: Therapeutic Potential of c-Abl Inhibitors" Antioxidants 14, no. 5: 611. https://doi.org/10.3390/antiox14050611

Guerra, M. V., Castro, J., Moreno, A., Balboa, E., Marugan, J. J., Alvarez, A. R., & Zanlungo, S. (2025). c-Abl/TFEB Pathway Activation as a Common Pathogenic Mechanism in Lysosomal Storage Diseases: Therapeutic Potential of c-Abl Inhibitors. Antioxidants, 14(5), 611. https://doi.org/10.3390/antiox14050611